A Novel Lumen-Apposing Metal Stent with an Electrocautery Tip for Different Indications: Initial Experience in a Referral Center.


Journal

Digestive diseases (Basel, Switzerland)
ISSN: 1421-9875
Titre abrégé: Dig Dis
Pays: Switzerland
ID NLM: 8701186

Informations de publication

Date de publication:
2022
Historique:
received: 04 03 2021
accepted: 19 07 2021
pubmed: 5 8 2021
medline: 7 7 2022
entrez: 4 8 2021
Statut: ppublish

Résumé

Recently, a new electrocautery lumen-apposing metal stent (EC-LAMS) has been launched. The primary aim of our study was to assess the feasibility of the freehand placement with intra-channel release of the new EC-LAMS. The secondary aims were to assess technical and clinical outcomes and rates of adverse events. We retrospectively evaluated 5 patients (3 F; mean age: 75.6 ± 14.6 years) who underwent new EC-LAMS placement for different indications (cholecystitis, malignant biliary obstruction, and malignant gastric outlet obstruction). We described all the procedures of EC-LAMS placement, providing also a video of one of them (see online suppl. material; for all online suppl. material, see www.karger.com/doi/10.1159/000518539). Technical and clinical success was achieved in all patients who underwent new EC-LAMS placement, and no AEs were experienced. All of the EC-LAMS were placed using the freehand technique with intra-channel release. Our initial experience with the new EC-LAMS showed a good performance of this device for different indications, especially if the stents are placed freehand and with intra-channel release. Further studies are needed to confirm our preliminary data and first impression about this new EC-LAMS.

Sections du résumé

BACKGROUND AND STUDY AIMS OBJECTIVE
Recently, a new electrocautery lumen-apposing metal stent (EC-LAMS) has been launched. The primary aim of our study was to assess the feasibility of the freehand placement with intra-channel release of the new EC-LAMS. The secondary aims were to assess technical and clinical outcomes and rates of adverse events.
PATIENTS AND METHODS METHODS
We retrospectively evaluated 5 patients (3 F; mean age: 75.6 ± 14.6 years) who underwent new EC-LAMS placement for different indications (cholecystitis, malignant biliary obstruction, and malignant gastric outlet obstruction). We described all the procedures of EC-LAMS placement, providing also a video of one of them (see online suppl. material; for all online suppl. material, see www.karger.com/doi/10.1159/000518539).
RESULTS RESULTS
Technical and clinical success was achieved in all patients who underwent new EC-LAMS placement, and no AEs were experienced. All of the EC-LAMS were placed using the freehand technique with intra-channel release.
CONCLUSIONS CONCLUSIONS
Our initial experience with the new EC-LAMS showed a good performance of this device for different indications, especially if the stents are placed freehand and with intra-channel release. Further studies are needed to confirm our preliminary data and first impression about this new EC-LAMS.

Identifiants

pubmed: 34348270
pii: 000518539
doi: 10.1159/000518539
pmc: PMC8450863
doi:

Substances chimiques

Metals 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

526-529

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Benedetto Mangiavillano (B)

Gastrointestinal Endoscopy Unit, Humanitas Mater Domini, Castellanza, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Francesco Auriemma (F)

Gastrointestinal Endoscopy Unit, Humanitas Mater Domini, Castellanza, Italy.

Laura Lamonaca (L)

Gastrointestinal Endoscopy Unit, Humanitas Mater Domini, Castellanza, Italy.

Alessandro Repici (A)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Digestive Endoscopy Unit, Humanitas Research Hospital, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH